Pharmacokinetics of alectinib and its metabolite M4 in a patient with advanced lung adenocarcinoma undergoing hemodialysis: A case report

Abstract This study presents the first detailed pharmacokinetic data of alectinib and its metabolite M4 in a patient with anaplastic lymphoma kinase (ALK)‐rearranged lung adenocarcinoma undergoing hemodialysis. When the patient was administered a daily 300 mg bid dose of alectinib, the maximal obser...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Main Authors: Ji Eun Park, Young‐Ran Yoon, Chang Ho Kim, Jaehee Lee
Formáid: Artigo
Teanga:Inglês
Foilsithe: Wiley 2022-04-01
Sraith:Thoracic Cancer
Ábhair:
alectinib
ALK rearrangement
lung cancer
M4
pharmacokinetics
Rochtain Ar Líne:https://doi.org/10.1111/1759-7714.14357
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla